← Evidence map

ArticleAmerican journal of translational research2020

Qiliqiangxin prevents right ventricular remodeling by inhibiting apoptosis and improving metabolism reprogramming with pulmonary arterial hypertension.

Yingdong Lu et al.PubMed ↗Full text ↗

No numbers read from the abstract.

18 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33042446